Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Express Scripts
AstraZeneca
McKesson
Colorcon

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Aurobindo Pharma Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA, and what generic and branded alternatives to AUROBINDO PHARMA drugs are available?

AUROBINDO PHARMA has three hundred and fifty-six approved drugs.

There are thirty-four tentative approvals on AUROBINDO PHARMA drugs.

Drugs and US Patents for Aurobindo Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd DOFETILDE dofetilide CAPSULE;ORAL 210740-001 Jan 22, 2019 AB RX No No   See Pricing   See Pricing
Aurobindo Pharma Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 202261-003 Nov 19, 2012 AB RX No No   See Pricing   See Pricing
Aurobindo Pharma Ltd AUROVELA FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 207580-001 Jun 15, 2017 AB RX No No   See Pricing   See Pricing
Aurobindo Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 206069-002 Mar 6, 2018 AB RX No No   See Pricing   See Pricing
Aurobindo Pharma Ltd TADALAFIL tadalafil TABLET;ORAL 206285-004 Mar 26, 2019 AB1 RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Colorcon
McKinsey
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.